New Medicines, Novel Insights: Accelerating development of cell and gene therapies

Cell and gene therapies offer extraordinary hope to patients with advanced cancers and genetic diseases but pose unprecedented challenges for sponsors. In this report, Parexel experts share insights that can bring these complex treatments to market faster and more efficiently.

Explore the report

Return to Insights Center

Related Insights

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Report

New Medicines, Novel Insights: Achieving patient-guided drug development

Oct 30, 2023

Video

Part 2: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021

Article

Australia: The Regulatory and Reimbursement Environment

Aug 28, 2023

Blog

ASGCT 2024: AAV Gene Therapy is Now, but Gene Editing is the Future

May 15, 2024

Blog

Accelerating Delivery and Patient Access to Rare Disease Treatments – Highlights from World Orphan Drug Congress

May 2, 2024

Blog

Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial

Nov 19, 2021

Whitepaper

The Chinese Pharmaceutical Market: Size, R&D, Regulations, Market Access and Innovations

Mar 9, 2023

Video

Part 3: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021

Article

Australia: Infrastructure and Innovations for Clinical Trials

Aug 28, 2023

Podcast

CAR-T boxed warnings: What comes next?

Mar 6, 2024

Blog

CAR-T product development: an assessment of FDA’s final guidance for industry

Feb 27, 2024

Related Insights

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Report

New Medicines, Novel Insights: Achieving patient-guided drug development

Oct 30, 2023

Video

Part 2: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021

Article

Australia: The Regulatory and Reimbursement Environment

Aug 28, 2023

Blog

ASGCT 2024: AAV Gene Therapy is Now, but Gene Editing is the Future

May 15, 2024

Blog

Accelerating Delivery and Patient Access to Rare Disease Treatments – Highlights from World Orphan Drug Congress

May 2, 2024

Show more